FDA Adverse Event Malfunction Summary report: N

LAP-BAND ADJUSTABLE GASTRIC BANDING SYSTEM 9.75CM

MDR report key: 2081968 · Received April 5, 2011

Report

Report Number
2024601-2011-00215
Event Type
Malfunction
Date Received
April 5, 2011
Date of Event
July 27, 2010
Report Date
March 9, 2011
Manufacturer
ALLERGAN
Product Code
LTI
PMA / PMN Number
P000008
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GA, US
Reporter Occupation
NO INFORMATION

Narratives

Additional Manufacturer Narrative · 1

MEDWATCH SENT TO FDA ON: (B)(4) /2011. THE PRODUCT ASSOCIATED WITH THIS REPORT HAS NOT YET BEEN RETURNED. BASED UPON THE IMPLANT DATE PROVIDED BY THE REPORTER, THE CONNECTOR TYPE IS ASSUMED TO BE A TAPER II. THE REPORTER OF THE EVENT WAS ASKED TO RETURN THE PRODUCT FOR ANALYSIS. VISUAL EXAMINATION MAY CONFIRM OR DETERMINE ANOTHER CONNECTOR TYPE ASSOCIATED WITH THIS REPORT. ALLERGAN HAS NOT RECEIVED THE PRODUCT AT THIS TIME. THEREFORE, NO ANALYSIS OR TESTING HAS BEEN DONE. PAIN IS A SURGICAL AND PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT. FURTHER INFORMATION FROM THE REPORTER REGARDING THE SERIAL NUMBER OF THE DEVICE HAS BEEN REQUESTED. DEVICE LABELING ADDRESSES THE POSSIBLE OUTCOME OF LEAKAGE AND PAIN AS FOLLOWS: "DEFLATION OF THE BAND MAY OCCUR DUE TO LEAKAGE FROM THE BAND, THE PORT OR THE CONNECTOR TUBING. OTHER ADVERSE EVENTS CONSIDERED RELATED TO THE LAP-BAND SYSTEM THAT OCCURRED IN FEWER THAN 1% OF SUBJECTS INCLUDED: ABDOMINAL PAIN, DEHYDRATION, CHEST PAIN, INCISION PAIN, AND ...PORT SITE PAIN."

Description of Event or Problem · 1

PATIENT REPORTED AN ALLEGED LEAK WITH A LAP-BAND PORT. THE PATIENT REPORTED "EXPERIENCING PAIN IN THE PORT AREA WHEN SITTING OR LYING DOWN". THE DEVICE REMAINS IMPLANTED. NO INFORMATION WAS GIVEN REGARDING THE SCHEDULING OF THE EXPLANT SURGERY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 LAP-BAND ADJUSTABLE GASTRIC BANDING SYSTEM 9.75CM LTI ALLERGAN NA NI

Patients

Seq Age Sex Outcome Treatment
1 48 YR Required Intervention NONE REPORTED